Derived from Current Agreements, our editors have selected notable M&A deals from the life sciences in recent weeks – our Featured deals. Subscribe to our weekly newsletter to be updated on new featured deals and much more.
For comprehensive access to all life science deals as they are announced:
Deal Monitor - part of Current Partnering Insight, Deal Monitor allows you to track recent deals by industry sector, therapy area, technology type and stage of development - access now
Current Agreements - search over 40,000 deals to find benchmarks, monitor target company deal structures, identify companies active in your area(s) of interest, and much more - access now
Featured M&A deals
All M&A deals: Deal Monitor | Current Agreements
Pfizer creates breaking news with Allergan purchase
November 23, 2015 : Allergan, big pharma, merger, Pfizer
US drugs giant Pfizer has sealed a deal to buy Botox-maker Allergan for $160bn (£106bn) in what is the biggest pharmaceuticals deal in history. more »
Celgene acquires Quanticel Pharmaceuticals
April 28, 2015 : big biotech, big pharma, Celgene, M&A
Celgene and Quanticel Pharmaceuticals announced a definitive share purchase agreement under which Celgene will acquire Quanticel more »
Teva bids to acquire Mylan as Perrigo rejects approach
April 22, 2015 : big pharma, M&A, Mylan, Teva
Teva Pharmaceutical announced a proposal to acquire all of the outstanding shares of Mylan in a transaction valued at $40 billion more »
Roche acquires Capp Medical
April 14, 2015 : big pharma, M&A
Roche has acquired CAPP Medical, a genomics research company more »
Mylan bids $29bn for Perrigo
April 13, 2015 : M&A
Horizon Pharma acquires Hyperion for $1.1 billion
April 1, 2015 : M&A
OptumRx acquired Catamaran in $13.2bn deal
April 1, 2015 : M&A
OptumRx and Catamaran have agreed to combine more »
Teva acquires Auspex for $3.2 billion
March 31, 2015 : big pharma, M&A, Teva
Teva and Auspex Pharmaceuticals have entered into a definitive merger agreement more »
Merger completed between Ranbaxy and Sunpharma
March 25, 2015 : generics, India, m&a news, Ranbaxy, sunpharma
Mumbai, India: March 25, 2015 – Sun Pharmaceutical Industries Ltd., begins the integration of Ranbaxy’s business following the successful closure of its merger. The integration, planned by Sun Pharma over many months, will focus on supporting strong growth. more »
Janssen acquires XO1 for ichorcumab
March 23, 2015 : big pharma, J&J, Janssen, M&A
Janssen Pharmaceuticals has acquired XO1 Limited more »
Derived from Current Agreements, more featured partnering deals by category:
Big pharma
Pfizer creates breaking news with Allergan purchase
November 23, 2015
When de-risking, relationships matter: How using key strategies can get you to your next innovative partnership
August 10, 2015
Big biotech
When de-risking, relationships matter: How using key strategies can get you to your next innovative partnership
August 10, 2015
Morphosys acquires Lanthio Pharma
May 7, 2015
Alexion to buy Synageva Biopharma
May 5, 2015
Pharma
Pfizer creates breaking news with Allergan purchase
November 23, 2015
When de-risking, relationships matter: How using key strategies can get you to your next innovative partnership
August 10, 2015
Biotech
When de-risking, relationships matter: How using key strategies can get you to your next innovative partnership
August 10, 2015
Veracyte banks $40 million private placement
April 28, 2015
Diagnostics
Roche acquires Signature Diagnostics for access to translational oncology and genomics
February 12, 2015
Personalis gains $33 million series C
January 14, 2015
Medical device
Mallinckrodt acquires Ikaria for $2.3bn
March 5, 2015
Drug delivery
Sanofi Pasteur and VBI Vaccines in formulation pact
April 9, 2015
